Symptoms, Side Effects and Adherence in the iPrEx Open-Label Extension

Background. Blinded clinical trials have reported a modest and transient “start-up syndrome” with initiation of tenofovir-based pre-exposure prophylaxis (PrEP). We evaluate this phenomenon and its effect on adherence in an open-label PrEP study. Methods. In the iPrEx open-label extension (OLE) study...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Clin Infect Dis
Hoofdauteurs: Glidden, David V., Amico, K. Rivet, Liu, Albert Y., Hosek, Sybil G., Anderson, Peter L., Buchbinder, Susan P., McMahan, Vanessa, Mayer, Kenneth H., David, Burns, Schechter, Mauro, Grinsztejn, Beatriz, Guanira, Juan, Grant, Robert M.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Oxford University Press 2016
Onderwerpen:
HIV/AIDS
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4826449/
https://ncbi.nlm.nih.gov/pubmed/26797207
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/ciw022
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items